CLINICAL_TRIALS
trial_result
· 2023-05-31
Clinical Trial Update: P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris [Phase 2]
Summary
A Phase 2 multi-center trial evaluating SB204 Gel for acne vulgaris has completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novan, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2023-05-31